European Stroke Treatment with Ancrod Trial "ESTAT"

Terminated

Phase 3 Results

Summary of Purpose

To compare ancrod vs. placebo in the treatment of ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • BASF Pharma

Trial Design

International, multi-center, double-blind, randomized, placebo-controlled trial of 1222 patients at 101 centers.

Contacts

Not available